Literature DB >> 25677555

Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury.

Yoshihiko Nakamura1, Akira Murai2, Mariko Mizunuma3, Daiki Ohta4, Yasumasa Kawano5, Norihiko Matsumoto6, Takeshi Nishida7, Hiroyasu Ishikura8.   

Abstract

INTRODUCTION: There are few investigations regarding the relationships between procalcitonin (PCT) and the acute kidney injury (AKI) in the diagnosis of sepsis. The purpose of this study was to clarify the diagnostic accuracy of the use of PCT levels in patients with or without AKI.
METHODS: This study was conducted as a single-center retrospective study. We enrolled 393 patients in whom PCT were measured on admission. We grouped the patients into non-AKI and AKI, and those with AKI were classified according to the RIFLE criteria (Risk, Injury, Failure). The patients in each group were further classified into the sepsis and the non-sepsis group. We subsequently investigated the diagnostic accuracy of the PCT for detecting sepsis in these groups.
RESULTS: The levels of PCT were significantly higher in the sepsis group than in the non-sepsis group among the non-AKI and each AKI patients (p < 0.0001). The diagnostic accuracy of the PCT for detecting sepsis was determined according to a ROC analysis; AUC value was 0.958 in the non-AKI group, in the Risk, Injury and Failure groups were 0.888 and 0.917, 0.857, respectively. AUC value for non-AKI group was significantly different from that of Failure group (p < 0.05).
CONCLUSIONS: In Failure AKI patients, the diagnostic accuracy of the PCT level is significantly lower than non-AKI patients. It is therefore suggested that we should be careful in using PCT value to diagnose sepsis in patients with Failure under RIFLE criteria.
Copyright © 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Diagnosis; Procalcitonin; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25677555     DOI: 10.1016/j.jiac.2014.12.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  12 in total

1.  Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.

Authors:  Yasuhiro Ebihara; Kiyoko Kobayashi; Akaru Ishida; Tomoya Maeda; Naoki Takahashi; Yoshitada Taji; Norio Asou; Kenji Ikebuchi
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

2.  Urinary exosomal activating transcriptional factor 3 as the early diagnostic biomarker for sepsis-induced acute kidney injury.

Authors:  Tanaporn Panich; Wiwat Chancharoenthana; Poorichaya Somparn; Jiraphorn Issara-Amphorn; Nattiya Hirankarn; Asada Leelahavanichkul
Journal:  BMC Nephrol       Date:  2017-01-07       Impact factor: 2.388

3.  Prognostic Value of High-Sensitivity C-Reactive Protein, Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis.

Authors:  Qiong Wu; Jun Nie; Fu-Xia Wu; Xiu-Lan Zou; Feng-Yi Chen
Journal:  Med Sci Monit       Date:  2017-03-30

4.  Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients.

Authors:  Kayeong Chun; Wookyung Chung; Ae Jin Kim; Hyunsook Kim; Han Ro; Jae Hyun Chang; Hyun Hee Lee; Ji Yong Jung
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

5.  Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.

Authors:  Ilaria Godi; Silvia De Rosa; Francesca Martino; Simona Bazzano; Marina Martin; Elisa Boni; Maria Rosa Carta; Claudia Tamayo Diaz; Gaia Mari; Anna Lorenzin; Massimo de Cal; Valentina Corradi; Carlotta Caprara; Davide Giavarina; Claudio Ronco
Journal:  Ann Intensive Care       Date:  2020-04-21       Impact factor: 6.925

6.  A novel procalcitonin-based score for detecting sepsis among critically ill patients.

Authors:  Tung-Lin Tsui; Ya-Ting Huang; Wei-Chih Kan; Mao-Sheng Huang; Min-Yu Lai; Kwo-Chang Ueng; Chih-Chung Shiao
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 7.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

Review 8.  Predictive Ability of Procalcitonin for Acute Kidney Injury: A Narrative Review Focusing on the Interference of Infection.

Authors:  Wei-Chih Kan; Ya-Ting Huang; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  Procalcitonin in bloodstream infections: beyond its role as a marker of clinical algorithm to reduce antimicrobial overuse.

Authors:  Yong Kyun Kim
Journal:  Korean J Intern Med       Date:  2017-12-28       Impact factor: 2.884

10.  Analysis of the diagnostic capabilities of urinary neutrophil gelatinase-associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care intensive care unit admission.

Authors:  Yuji Imoto; Ayano Wakasaki; Kumiko Izumida; Hiroshi Shimada; Kumiko Ohkubo; Yasumasa Kawano; Hiroyasu Ishikura; Akira Matsunaga
Journal:  J Clin Lab Anal       Date:  2021-06-08       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.